Literature DB >> 20218632

Potent glucosidase inhibitors: de-O-sulfonated ponkoranol and its stereoisomer.

Razieh Eskandari1, Douglas A Kuntz, David R Rose, B Mario Pinto.   

Abstract

Ponkoranol, a glucosidase inhibitor isolated from the plant Salacia reticulata, comprises a sulfonium ion with an internal sulfate counterion. An efficient synthetic route to de-O-sulfonated ponkoranol and its 5'-stereoisomer is reported, and it is shown that these compounds are potent glucosidase inhibitors that inhibit a key intestinal human glucosidase, the N-terminal catalytic domain of maltase glucoamylase, with K(i) values of 43 +/- 3 and 15 +/- 1 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20218632     DOI: 10.1021/ol1004005

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC-MS with ion pair chromatography.

Authors:  Osamu Muraoka; Toshio Morikawa; Sohachiro Miyake; Junji Akaki; Kiyofumi Ninomiya; Yutana Pongpiriyadacha; Masayuki Yoshikawa
Journal:  J Nat Med       Date:  2010-10-28       Impact factor: 2.343

2.  Modulation of starch digestion for slow glucose release through "toggling" of activities of mucosal α-glucosidases.

Authors:  Byung-Hoo Lee; Razieh Eskandari; Kyra Jones; Kongara Ravinder Reddy; Roberto Quezada-Calvillo; Buford L Nichols; David R Rose; Bruce R Hamaker; B Mario Pinto
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

Review 3.  A review of antidiabetic active thiosugar sulfoniums, salacinol and neokotalanol, from plants of the genus Salacia.

Authors:  Toshio Morikawa; Kiyofumi Ninomiya; Genzoh Tanabe; Hisashi Matsuda; Masayuki Yoshikawa; Osamu Muraoka
Journal:  J Nat Med       Date:  2021-04-26       Impact factor: 2.343

Review 4.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.